Diabeloop filed European patent EP3438858A1 covering closed-loop blood glucose control systems and methods. The patent application includes algorithmic processing for automated insulin delivery, continuous glucose monitoring integration, and personalized diabetes management. Inventors include Sylvain Rousson, Romain Blanc, and Maeva Doron. The patent is designated for all EU member states plus Switzerland, Norway, Turkey, and other European countries.

Medical device manufacturers developing automated insulin delivery systems should review this patent for freedom-to-operate analysis. Healthcare providers and patients using Diabeloop's technology can expect continued intellectual property protection. No immediate compliance actions are required as this is a patent publication rather than a regulatory requirement.